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Introduction
To the best of our knowledge circulating miRNAs in
TRAPS, as well as in other monogenic autoinflammatory
disorders have never been investigated.
Objectives
To evaluate circulating microRNAs (miRNAs) levels in
patients with tumor necrosis factor-receptor associated
periodic syndrome (TRAPS), in comparison to healthy
controls, and to correlate their levels to parameters of
disease activity and/or disease severity.
Methods
Expression levels of circulating miRNAs were measured
by Agilent microarrays in 29 serum samples from 15
TRAPS patients carrying mutations known to be asso-
ciated with high disease penetrance and 8 healthy con-
trols. Differentially expressed and clinically relevant
miRNAs were detected using GeneSpring GX software.
Results
We identified a 6 miRNAs signature able to discriminate
TRAPS from healthy controls. Moreover, 4 miRNAs
were differentially expressed between patients treated
with the interleukin (IL)-1 receptor antagonist anakinra
and untreated patients. Of these, miR-92a-3p expression
was found to be reduced in untreated patients, while its
expression levels were similar to healthy controls in
samples obtained during anakinra treatment. MiR-92b
levels were inversely correlated with the number of fever
attacks/year during the 1st year from the index attack of
TRAPS, while miR-377-5p levels were positively corre-
lated with serum amyloid A (SAA) circulating levels.
Conclusion
Serum miRNAs levels show a baseline pattern in
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